Metall Zug Ag Class B · SIX:METN
Metall Zug Ag Class B — H1 2025 Earnings Presentation
37 slides from Metall Zug Ag Class B's earnings presentation, Aug 25, 2025
Slide 1: Investor Presentation Metall Zug AG - Welcome
Investor Presentation Metall Zug AG - Welcome August 25, 2025 Matthias Rey, CEO Urs Scherrer, CFO
Slide 2: Content
METALL ZUG GROUP Content 1. Group Financial Report 2. Business Units − Medical Devices − Technologycluster & Infrastructure − Investments & Corporate 3. Information for Investors Investor Presentation - August 25, 2025 2
Slide 3: What we have planned and what we achieved in HY 1/25
METALL ZUG GROUP What we have planned and what we achieved in HY 1/25 − Product launches and further R&D push, digitalization of devices and product updates − Increase sales with a focus on US and Asian markets − Review the implementation of strategic initiatives − Obtaining building permit for Crea
Slide 4: Group Financial Report HY1/2025
Group Financial Report HY1/2025 Metall Zug Group Investor Presentation - August 25, 2025 Medical Devices Technologycluster & Investments & Corporate Infrastructure
Slide 5: Income Statement
METALL ZUG GROUP Income Statement Metall Zug Group HY 1/25 in % HY 1/24 in % Comment (in CHF million) Net sales 94.2 100.0 181.2 100.0 Cost of Goods and Services sold -63.2 -67.1 -123.2 -68.0 Gross Profit 31.0 32.9 57.9 32.0 Marketing and sales expenses -13.9 -14.8 -26.7 -14.7 Research and developme
Slide 6: Strategic Investments
METALL ZUG GROUP Strategic Investments Multi Energy Metall Zug Group Komax Group V-ZUG Group SteelcoBelimed Zug AG Total (in CHF million) HY 1/25 proportional result -1.1 0.5 -4.5 0.0 -5.1 Book value (proportional equity) 85.3 145.3 53.6 0.0 284.2 Market value (share price as of June 30) 124.2 126.2
Slide 7: Net Sales HY 1/25
Net Sales HY 1/25 by Business Unit by region 12% 18% (18%) (13%) 22% (15%) 37% 82% (39%) (45%) 29% (33%) Medical Devices Infection Control 0% (37%) Switzerland Investments & Corporate Europe w/o Switzerland Technologycluster & Infrastructure 0% (0%) Americas Asia/Pacific/Others (Previous year’s valu
Slide 8: Net Sales Analysis
METALL ZUG GROUP Net Sales Analysis 200.0 180.0 181.2 -3.3 -0.1 -0.2 -82.1 160.0 140.0 in CHF million 120.0 100.0 -1.2 94.2 80.0 60.0 40.0 20.0 0.0 181.2 -3.3 -0.1 -0.2 -82.1 -1.2 94.2 Net Sales Medical Devices Technologycluster & Investments & Deconsolidation FX Net Sales HY 1/24 Infrastructure Cor
Slide 9: Operating Result (EBIT) Analysis
METALL ZUG GROUP Operating Result (EBIT) Analysis 70.0 60.0 58.5 -5.0 -0.5 -2.4 -3.7 50.0 -66.6 40.0 30.0 in CHF million 20.0 10.0 0.0 -12.6 7.1 -10.0 -20.0 -30.0 58.5 -5.0 -0.5 -2.4 -3.7 -66.6 7.1 -12.6 EBIT Medical Devices Technologycluster & Investments & I&C Strategic Book Gain Deconsolidation E
Slide 10: Balance Sheet
METALL ZUG GROUP Balance Sheet Metall Zug Group 06/30/2025 in % 12/31/2024 in % Comment (in CHF million) Cash and cash equivalents / securities 14.6 2.3 17.2 2.7 Other current assets 114.6 17.7 112.3 17.7 Current assets 129.2 20.0 129.5 20.5 Tangible assets 179.8 27.8 168.7 26.6 Includes book values
Slide 11: Cash Flow Statement
METALL ZUG GROUP Cash Flow Statement Metall Zug Group HY 1/25 HY 1/24 Comment (in CHF million) Cash flow from operating activities -5.4 6.7 Cash flow from investing activities -27.1 -18.6 - of which investments in tangible assets -16.7 -14.1 - of which investments in financial assets -14.2 0.0 HY 1/
Slide 12: Business Units
Business Units Metall Zug Group Investor Presentation - August 25, 2025 Medical Devices Technologycluster & Investments & Corporate Infrastructure
Slide 13: Medical Devices
Medical Devices Medical Devices Investor Presentation - August 25, 2025
Slide 14: Key figures
MEDICAL DEVICES Key figures HY 1/25 HY 1/24 (in CHF million) Net sales 77.1 81.6 Net sales development in % -5.6 -13.1 - of which foreign currency impact in % -1.5 -1.2 Organic net sales development in % -4.1 -11.8 Investments (expenses) in research and development -12.6 -13.3 Operating income (EBIT
Slide 15: Net Sales
MEDICAL DEVICES Net Sales Net sales by region Net sales by product area in % in % 5% 15% (5%) 13% (16%) (11%) 41% (44%) 21% (20%) 36% (38%) 45% 5% (41%) (7%) 20% Switzerland (18%) Europe w/o Switzerland General Diagnostic Americas Specialities Asia/Pacific/Others Simulation Chairs & Stands Accessori
Slide 16: US tariff policy
MEDICAL DEVICES US tariff policy − Tariff policy in important US market, where around 40% of sales is generated, has led to uncertainties − Haag-Streit has local production facilities in the US for chairs and stands - only around half of its US sales are affected by the high tariffs on Swiss exports
Slide 17: Metis 900
MEDICAL DEVICES Metis 900 − High-quality surgical microscope − Stable & brilliant red reflex − Outstanding ergonomics, delivering a more comfortable working experience − Efficient control through programmable foot and hand switches − Assistant microscope supporting surgical teaching & training Intro
Slide 18: Elara 900
MEDICAL DEVICES Elara 900 − World novelty: first hybrid-digital slit lamp − Represents important step towards efficiency through digitalization − Outstanding image sharpness and precision thanks to proven Swiss optics and revolutionary projector lighting − Two integrated cameras enable a detailed 3D
Slide 19: Refractor 900
MEDICAL DEVICES Refractor 900 − Digital phoropter − Accelerate refraction processes due to fast lens exchange − Precise prescription thanks to 1/8 diopter increments − Intelligent connectivity: integrates seamlessly with EMR systems, diagnostic devices and vision testing solutions. − With this produ
Slide 20: Further growth in product portfolio
MEDICAL DEVICES Further growth in product portfolio − Launch of further innovative products is planned for the coming years Metis 900 − Renewal and further digitalization of portfolio Refractor 900 − New products will strengthen and expand market position Elara 900 − In the medium term, ratio of R&D
Slide 21: Ophthalmological expertise
MEDICAL DEVICES Ophthalmological expertise Prof. Dr. Sandrine Zweifel Dr. Thomas Lenzen Appointed as new member of the Board of Directors of Metall Appointed as new CEO of the Haag-Streit Group as of Zug on May 9, 2025 September 1, 2025 − Titularprofessor, University of Zurich; Private Lecturer, Ven
Slide 22: Technologycluster & Infrastructure
Technologycluster & Infrastructure Investor Presentation - August 25, 2025
Slide 23: Key figures
TECHNOLOGYCLUSTER & INFRASTRUCTURE Key figures HY 1/25 HY 1/24 (in CHF million) Net sales 0.0 0.1 Other operating income 6.5 6.6 Operating income (EBIT) 0.8 1.3 Employees (FTE) 30.0 31.0 CAPEX Total Rental income (in CHF million, Cash-flow-view) (in CHF million) 14.7 4.6 4.6 9.7 HY 1/24 HY 1/25 HY 1
Slide 24: Site overview
TECHNOLOGYCLUSTER & INFRASTRUCTURE Site overview Investor Presentation - August 25, 2025 24
Slide 25: SHL Südtor: New Headquarter SHL Medical
TECHNOLOGYCLUSTER & INFRASTRUCTURE SHL Südtor: New Headquarter SHL Medical Project Description & Usage Industrial and production building for drug delivery systems and medical technology, office tower with 350-400 workstations, 65% commercial, 35% office Construction & Specialties • First building f
Slide 26: CreaTower I: VZ Depotbank
TECHNOLOGYCLUSTER & INFRASTRUCTURE CreaTower I: VZ Depotbank Project Description & Usage Office high-rise with innovative supporting structure made of prefabricated concrete elements, cafeteria, 90% office use, 10% gastronomy Construction & Specialties • Floor slabs made of non-reinforced precast co
Slide 27: RefActory: Center of Tech Cluster
TECHNOLOGYCLUSTER & INFRASTRUCTURE RefActory: Center of Tech Cluster Project Description & Usage Commercial building, which houses the Zugorama exhibition of V-ZUG on the ground floor and 1st floor, ground floor also a shop and a restaurant, upper floors office/commercial uses, 60% office, 10% gastr
Slide 28: Project Pi: Residential high-rise
TECHNOLOGYCLUSTER & INFRASTRUCTURE Project Pi: Residential high-rise Project Description & Usage Residential high-rise 80m with approx. 180 apartments, commercial space on the ground floor, daycare center in the adjoining building - 22 floors of affordable housing, 4 floors of location-conform housi
Slide 29: Investments & Corporate
Investments & Corporate Investor Presentation - August 25, 2025
Slide 30: Key figures
INVESTMENTS & CORPORATE Key figures HY 1/25 HY 1/24 (in CHF million) Net sales 17.1 32.8 Net sales developtment in % -47.7 -34.6 of which foreign currency impact in % 0.0 -0.2 of which acquisition & divestment impact in % -47.1 -10.0 Organic net sales development in % -0.7 -24.4 Net sales to third p
Slide 31: Key topics
INVESTMENTS & CORPORATE Key topics − Positive development recorded in order intake (several major projects won, and number of new service contracts increased) − Sales of the new Ariane dishwasher range („Swiss made“) are picking up speed. − Around 20% of Ariane orders are placed via sustainable circ
Slide 32: Key topics
INVESTMENTS & CORPORATE Key topics − Post-merger integration process is progressing rapidly − First cost synergies will be visible in current year − Service business developed favorably with positive impact on margins − The Innovation Hub in Zug opened in July − Starting September 2025 the SteelcoBe
Slide 33: We are happy to answer your questions
Q A We are happy to answer your questions Investor Presentation - August 25, 2025
Slide 34: Information for Investors Metall Zug Group
Information for Investors Metall Zug Group Investor Presentation - August 25, 2025
Slide 35: Financial calendar
METALL ZUG GROUP Financial calendar March 23, 2026 Publication Annual Report 2025 / Earnings Conference May 8, 2026 General Meeting of the Shareholders 2026 August 24, 2026 Publication of Half-year Report Investor Presentation - August 25, 2025 35
Slide 36: Contact
METALL ZUG GROUP Contact Urs Scherrer CFO Bettine Killmer Head of Corporate Communications & Investor Relations Metall Zug AG Industriestrasse 66 (postal address), Grienbachstrasse 11 (office address) 6302 Zug Switzerland investorrelations@metallzug.ch Phone: +41 58 768 60 50 Investor Presentation -
Slide 37: Disclaimer
METALL ZUG GROUP Disclaimer Metall Zug AG has made great efforts to include accurate and up-to-date information in this document. However, we make no representations or warranties, expressed or implied, as to the accuracy or completeness of the information provided in this document and disclaim any